CBI apprehends persons over bribery case at DCGI office, role of Joint Drugs Controller under scanner

The searches were conducted as part of this operation, officials said.

Published On 2022-06-20 12:10 GMT   |   Update On 2022-06-21 12:18 GMT
Advertisement

New Delhi: The Central Bureau of Investigation (CBI) on Monday apprehended some persons at the office of the Drugs Controller General of India (DCGI) in connection with a Rs three lakh alleged bribery case in which the role of Joint Drugs Controller S Eswara Reddy is under scanner, officials said.

The CBI team, after getting inputs about exchange of bribery, allegedly carried out trap operation in which some persons were apprehended, they said.

The searches were conducted as part of this operation, they said.

Read also: HC restrains pharma companies from infringing Boehringer Ingelheim diabetes drug Linagliptin

Drugs Controller General of India (DCGI) is the head of department of the Central Drugs Standard Control Organization of the Government of India responsible for approval of licences of specified categories of drugs such as blood and blood products, IV fluids, vaccines, and sera in India. Drugs Controller General of India, comes under the Ministry of Health & Family Welfare.DCGI also sets standards for manufacturing, sales, import, and distribution of drugs in India.

Read also: Abbott Healthcare faces 5 year ban from Tamil Nadu Govt agency: Report







Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News